Trientine Hydrochloride for the Prevention of Macular Edema Associated With Pan-retinal Photocoagulation for Severe Non-proliferative and Proliferative Diabetic Retinopathy

NCT01213888 · clinicaltrials.gov ↗
NA
Phase
TERMINATED
Status
3
Enrollment
OTHER
Sponsor class

Stopped Low enrollment \& superior treatments available for diabetic macular edema including anti-VEFG therapies such as bevacizumab and ranibizumab.

Conditions

Interventions

Sponsor

University of British Columbia